Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002
Published online before print January 10, 2002, doi: 10.1161/hh0302.104724
A more recent version of this article appeared on February 22, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/3/277    most recent
hh0302.104724v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hathaway, C. A.
Right arrow Articles by Miller Jr, F. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hathaway, C. A.
Right arrow Articles by Miller Jr, F. J.
Related Collections
Right arrow Pathophysiology
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors

Submitted on August 9, 2001
Revised on December 21, 2001
Accepted on December 21, 2001

Regression of Atherosclerosis in Monkeys Reduces Vascular Superoxide Levels

Christopher A. Hathaway , Donald D. Heistad , Donald J. Piegors , and Francis J. Miller Jr *

From the Department of Internal Medicine, University of Iowa College of Medicine and VA Medical Center, Iowa City, Iowa.

* To whom correspondence should be addressed. E-mail: francis-miller{at}uiowa.edu.

Superoxide (O2·-) in arteries may contribute to atherosclerosis in part by inactivation of nitric oxide. We hypothesized that regression of atherosclerosis in nonhuman primates is associated with a decrease in vascular NAD(P)H oxidase, decreased O2·- levels, and improved endothelium-dependent relaxation. Cynomolgus monkeys (n=28) were fed an atherogenic diet for 47±10 (mean±SE) months. In carotid arteries (containing advanced lesions), femoral arteries (moderate lesions), and saphena arteries (minimal lesions), we examined O2·- levels and vasomotor function. Compared with vessels from normal monkeys (n=8), O2·- levels (measured by lucigenin-enhanced chemiluminescence) were 3.3-fold higher in carotid, 1.7-fold higher in femoral, and not different in saphena arteries from atherosclerotic monkeys. Dihydroethidium staining also demonstrated increased O2·- levels throughout the vessel wall in femoral and carotid arteries from atherosclerotic monkeys. Components of the NAD(P)H oxidase (p22phox and p47phox) were increased in atherosclerotic arteries, and immunohistochemistry demonstrated colocalization primarily to areas of macrophage infiltration. Relaxation to acetylcholine was impaired in carotid and femoral, but not saphena, arteries from atherosclerotic monkeys. After 8 months of regression diet (n=9), serum cholesterol decreased to normal, and O2·- levels (basal and NAD(P)H-stimulated), as well as expression of NAD(P)H oxidase, returned toward normal. Relaxation to acetylcholine improved in femoral arteries, but not in the more diseased carotid arteries. We conclude that, in a primate model of moderately severe atherosclerosis and regression of atherosclerosis, changes in endothelial function are inversely related to O2·- and NAD(P)H oxidase levels. Reduction in vascular O2·- during regression of atherosclerosis may contribute to improvement in vasomotor function.


Key words: oxidative stress • vascular reactivity • blood vessels • macrophages • endothelium




This article has been cited by other articles:


Home page
CirculationHome page
J. D. Miller, R. M. Weiss, K. M. Serrano, R. M. Brooks II, C. J. Berry, K. Zimmerman, S. G. Young, and D. D. Heistad
Lowering Plasma Cholesterol Levels Halts Progression of Aortic Valve Disease in Mice
Circulation, May 26, 2009; 119(20): 2693 - 2701.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Tsimikas, M. Aikawa, F. J. Miller Jr, E. R. Miller, M. Torzewski, S. R. Lentz, C. Bergmark, D. D. Heistad, P. Libby, and J. L. Witztum
Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio With Concomitant Depletion of Oxidized Phospholipids From Atherosclerotic Lesions After Dietary Lipid-Lowering: A Potential Biomarker of Early Atherosclerosis Regression
Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Ohashi, M. S. Runge, F. M. Faraci, and D. D. Heistad
MnSOD Deficiency Increases Endothelial Dysfunction in ApoE-Deficient Mice
Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2331 - 2336.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. Gorenne, M. Kavurma, S. Scott, and M. Bennett
Vascular smooth muscle cell senescence in atherosclerosis
Cardiovasc Res, October 1, 2006; 72(1): 9 - 17.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Matthews, I. Gorenne, S. Scott, N. Figg, P. Kirkpatrick, A. Ritchie, M. Goddard, and M. Bennett
Vascular Smooth Muscle Cells Undergo Telomere-Based Senescence in Human Atherosclerosis: Effects of Telomerase and Oxidative Stress
Circ. Res., July 21, 2006; 99(2): 156 - 164.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. D. Heistad
Oxidative Stress and Vascular Disease: 2005 Duff Lecture
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 689 - 695.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. Symons, J. C. Rutledge, U. Simonsen, and R. A. Pattathu
Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H181 - H191.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Iida, Y. Chu, J. Francis, R. M. Weiss, C. A. Gunnett, F. M. Faraci, and D. D. Heistad
Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H525 - H532.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J.-M. Li and A. M Shah
Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1014 - R1030.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Sato, T. Komaru, H. Shioiri, S. Takeda, K. Takahashi, H. Kanatsuka, M. Nakayama, and K. Shirato
Hypercholesterolemia Impairs Transduction of Vasodilator Signals Derived From Ischemic Myocardium: Myocardium-Microvessel Cross-Talk
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 2034 - 2039.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. S Conklin, W. Fu, P. H Lin, A. B Lumsden, Q. Yao, and C. Chen
HIV protease inhibitor ritonavir decreases endothelium-dependent vasorelaxation and increases superoxide in porcine arteries
Cardiovasc Res, July 1, 2004; 63(1): 168 - 175.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kawashima and M. Yokoyama
Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 998 - 1005.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Munzel, R. Feil, A. Mulsch, S. M. Lohmann, F. Hofmann, and U. Walter
Physiology and Pathophysiology of Vascular Signaling Controlled by Cyclic Guanosine 3',5'-Cyclic Monophosphate-Dependent Protein Kinase
Circulation, November 4, 2003; 108(18): 2172 - 2183.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Lassegue and R. E. Clempus
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R277 - R297.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Mollnau, E. Schulz, A. Daiber, S. Baldus, M. Oelze, M. August, M. Wendt, U. Walter, C. Geiger, R. Agrawal, et al.
Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells
Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 615 - 621.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Zhang, T. W. Hein, W. Wang, and L. Kuo
Divergent Roles of Angiotensin II AT1 and AT2 Receptors in Modulating Coronary Microvascular Function
Circ. Res., February 21, 2003; 92(3): 322 - 329.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Dayal, K. L. Brown, C. J. Weydert, L. W. Oberley, E. Arning, T. Bottiglieri, F. M. Faraci, and S. R. Lentz
Deficiency of Glutathione Peroxidase-1 Sensitizes Hyperhomocysteinemic Mice to Endothelial Dysfunction
Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 1996 - 2002.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. G. Bucciarelli, T. Wendt, W. Qu, Y. Lu, E. Lalla, L. L. Rong, M. T. Goova, B. Moser, T. Kislinger, D. C. Lee, et al.
RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E-Null Mice
Circulation, November 26, 2002; 106(22): 2827 - 2835.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. R. Lentz, F. J. Miller Jr, D. J. Piegors, R. A. Erger, J. A. Fernandez, J. H. Griffin, and D. D. Heistad
Anticoagulant Responses to Thrombin Are Enhanced During Regression of Atherosclerosis in Monkeys
Circulation, August 13, 2002; 106(7): 842 - 846.
[Abstract] [Full Text] [PDF]